PORKEROpen the app

House bill · 119th Congress · Latest step: Introduced

Drug Shortage Compounding Patient Access Act of 2025

H.R. 5316Introduced Sep 11, 2025Policy area: Health

Official title: To amend the Federal Food, Drug, and Cosmetic Act to ensure patients have access to certain shortage and urgent-use compounded medications, and for other purposes.

Open in Bill Explorer →

Where it went

Latest action: Sep 11, 2025 — Referred to the House Committee on Energy and Commerce.

Cost and committee reports

Official records Congress.gov attaches to H.R. 5316.

Congress.gov’s record for this bill does not list a CBO cost estimate or a committee report (as of July 6, 2026). Not every bill gets one.

From the Congress.gov bill record for H.R. 5316, last updated July 6, 2026. PORKER’s copy was retrieved September 13, 2026 and is refreshed nightly. Open “Evidence” on any line for the record, field and file fingerprint.

Vote results

No recorded roll-call votes on this bill in PORKER’s records (voice votes and unanimous consent are not roll calls; roll-call records start in 2011).

Cosponsors

3 cosponsors — 3 Republicans

0 of 3 cosponsors (0%) are from the other party.

Earl Carter (R-GA), Andy Harris (R-MD), Burgess Owens (R-UT).

More from the sponsor

Other 119th Congress bills sponsored by Rep. Diana Harshbarger.

Sponsor’s state and district

Tennessee in Congress · TN-1 district

Open in Bill Explorer →

Data as of Sep 25, 2026 · bill record checked by PORKER from Congress.gov · votes from Senate.gov and the House Clerk. PORKER is non-partisan.